Home » Headlines » Currently Reading:

Morning Headlines 2/1/13

February 1, 2013 Headlines No Comments

McKesson Q3 Profit Misses Estimate; Cuts FY13 Adj. EPS View

McKesson reports Q3 results: EPS $1.41 compared to last year’s $1.40, missing analyst estimates of $1.63. Revenue was up one percent, ending the quarter at $31.2 billion. The company lowered its guidance for FY 2013 by 20 cents, to $7.10-$7.30. The stock closed down 0.4 percent on the day.

Computer Programs and Systems, Inc. Announces Fourth Quarter and Year-End 2012 Results

CPSI reports year-end results, with revenue up five percent at $183 million. Net income increased 16 percent to $30 million, but EPS missed the $0.88 analyst estimate by $0.05 and shares dropped nearly nine percent in after-hours trading.

Clancy stepping down as AHRQ director

After 10 years on the job, Carolyn Clancy, MD, is stepping down as the director of AHRQ.

Piedmont Newnan transitioning to electronic medical record system

136-bed Piedmont Newnan Hospital goes live on Epic this Friday, the first within the five-hospital Piedmont Healthcare system’s network-wide implementation.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Vaporware?: JTR, Cerner is re-tooling itself from a software company (sic) into a service company. The company needs a place to put ...
  • Dave Butler: Many similar issues that I've found as well during my time with provider groups. The EHRs screen can be really busy and ...
  • Justa Trench Rat: Nice to see Cerner continuing with their new campus. I am sure our implementation of their highly questionable revenue ...
  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links